ft 04 feb 94 intern compani news sale rise lilli still post loss eli lilli us drug group record faster expect sale growth 9 per cent dollar 1 8bn last quarter 1993 compar year dollar 1 2bn restructur charg drag group loss higher sale support product axid humatrop prozac vancocin compani said sale ceclor antibiot lilli second biggest product prozac anti depress declin slightli year ad due previous announc charg compani report net loss quarter dollar 523 6m dollar 1 77 share exclud one item net incom would risen dollar 332 4m dollar 1 14 dollar 311 1m dollar 1 06 year ago lilli took restructur charg dollar 46 1m pre tax like compani lilli experienc slow us market sale last year grew 4 per cent held back downward pressur price result medicaid rebat increas dollar 156m greater particip manag care programm sale outsid us grew 6 per cent take overal sale 5 per cent dollar 6 5bn pharmaceut account dollar 4 75bn 7 per cent medic devic diagnost earmark dispos dollar 1 25bn 4 per cent year whole net incom fell dollar 480m dollar 1 63 dollar 709m dollar 2 41 1992